Tempe-based GT Medical Technologies Inc. raised $45 million to expand its technology to treat patients with operable brain tumors.
The funding will be used to expand the company's commercialization of its GammaTile Therapy, a targeted radiation therapy the U.S. Food and Drug Administration cleared in July 2018 for patients with operable brain tumors, according to GT Medical Technologies.
This series C financing follows a $16 million raise in November 2020 and a $10 million raise in early 2019.…
